Germany Oncology Therapeutics Market Size, Share, and COVID-19 Impact Analysis, By Drugs (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Others), By Therapy (Chemotherapy, targeted Therapy, and Immunotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Germany Oncology Therapeutics Market Insights, Industry Trend, Forecasts to 2033

Germany Oncology Therapeutics Market Insights Forecasts to 2033

• The Germany Oncology Therapeutics Market Size Was Valued at USD 7.0 Billion in 2023.
• The Germany Oncology Therapeutics Market Size is Growing at a CAGR of 6.55% from 2023 to 2033
• The Germany Oncology Therapeutics Market Size is Expected to reach USD 13.2 Billion by 2033

The Germany Oncology Therapeutics Market Size is Anticipated to Exceed USD 13.2 Billion by 2033, Growing at a CAGR of 6.55% from 2023 to 2033. The rising prevalence of cancer and the presence of a strong pipeline of drugs are driving the oncology therapeutics market in the Germany.     

Market Overview

The oncology therapeutics market refers to the industry encompassing the demand for medications and treatments used for managing and treating various forms of cancer. Oncology therapeutics include the treatment and medications used for diagnosing and treating cancer. It includes surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. The growing prevalence of cancer, along with the changing lifestyle, geriatric population, and environmental factors like pollution, as well as the growing infrastructure development, are significantly contributing to driving the oncology therapeutics market. Furthermore, advances in targeted therapies and immunotherapy, as well as the demand for better & more precise cancer therapeutics, are escalating the growth opportunities in the oncology therapeutics market. 

Report Coverage

This research report categorizes the market for the Germany oncology therapeutics market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Germany oncology therapeutics market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Germany oncology therapeutics market.

Driving Factors

The increasing prevalence of cancer is driving the treatment modalities for cancers such as surgery, chemotherapy, radiation therapy, hormone therapy, immunotherapy, and targeted therapy, thereby propelling the oncology therapeutics market. It was estimated that 231,400 women and 261,800 men in Germany were diagnosed with cancer in the year 2020. A strong pipeline of cancer therapeutic drugs, particularly through companies like Merck KGaA and others, is significantly driving the market growth.

Restraining Factors

The adverse effects of oncology therapeutics drugs, stringent government regulations, and patent expiration are hindering the oncology therapeutics market. Further, the increased cost of oncology therapeutic drugs is challenging the market.

Market Segmentation

The Germany oncology therapeutics market share is classified into drugs, therapy, and distribution channel.

• The targeted drugs segment dominated the market with the largest market share in 2023 and is expected to grow at a significant CAGR during the projected timeframe.

Based on the drugs, the Germany oncology therapeutics market is divided into cytotoxic drugs, targeted drugs, hormonal drugs, and others. Among these, the targeted drugs segment dominated the market with the largest market share in 2023 and is expected to grow at a significant CAGR during the projected timeframe. Targeted drugs or chemotherapy aim to minimize drug side effects on normal cells. The rising demand for targeted therapies and advancements in drug delivery systems are significantly contributing to propelling the market.

• The targeted therapy segment dominated the market with the largest market share in 2023 and is expected to grow at a significant CAGR during the projected timeframe.

Based on the therapy, the Germany oncology therapeutics market is divided into chemotherapy, targeted therapy, and immunotherapy. Among these, the targeted therapy segment dominated the market with the largest market share in 2023 and is expected to grow at a significant CAGR during the projected timeframe. The therapy inhibits the growth and spread of cancer cells without harming the healthy cells, by precisely targeting the specific molecules or genetic changes within cancer cells.  The inclination towards targeted drugs for treating various types of cancer is propelling the market in the targeted therapy segment. 

• The hospital pharmacies segment is dominating the market with a major market share and is expected to grow at a significant CAGR during the projected timeframe.

Based on the distribution channel, the Germany oncology therapeutics market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. Among these, the hospital pharmacies segment is dominating the market with a major market share and is expected to grow at a significant CAGR during the projected timeframe. The advantage of hospital pharmacies is that patients receive infusions or have merged their care with hospital services. The increasing medication prescriptions and diagnosis frequency at hospital pharmacies are responsible for propelling the market growth in the hospital pharmacies segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Germany oncology therapeutics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Merck KGaA
• Bayer AG
• Beohringer Ingelheim
• CureVac
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In January 2023, Boehringer Ingelheim and 3T Biosciences announced that they have entered into a strategic collaboration and licensing agreement for discovering and developing next-generation cancer therapies to address high unmet patient needs. 

Market Segment

This study forecasts revenue at Germany, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Germany Oncology Therapeutics Market based on the below-mentioned segments:

Germany Oncology Therapeutics Market, By Drugs

• Cytotoxic Drugs
• Targeted Drugs
• Hormonal Drugs
• Others

Germany Oncology Therapeutics Market, By Therapy

• Chemotherapy
• Targeted Therapy
• Immunotherapy

Germany Oncology Therapeutics Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies